Literature DB >> 12897907

Hepatitis C virus seroprevalence rate among Saudis.

Ossama A Shobokshi1, Frank E Serebour, Abdullah Z Al-Drees, Ahmed H Mitwalli, Ahmad Qahtani, Leila I Skakni.   

Abstract

OBJECTIVE: The aim of the study is to determine the seroprevalence of hepatitis C virus (HCV) in blood donors, children, pregnant women, hemodialysis patients and drug addicts in Saudi Arabia.
METHODS: Using third generation enzyme immunoassay kits, we have screened Saudi cohorts of all ages and sexes, namely infants, pre-school, school children, young adults and adults (blood donors and antenatals) for antibodies to HCV. We have also reviewed HCV seroprevalence data among high risk groups from 1998 to 2002.
RESULTS: An overall 1.1% (6313 out of 557813) seroprevalence rate was determined among Saudi blood donors; 0.1% (5 out of 3854) in Saudi children; and 0.7% (22 out of 3127) among pregnant women. Hemodialysis patients remain at highest risk of infection at 55.7% whereas intravenous drug addicts have 14% exposure rate.
CONCLUSION: We conclude that the present public health schemes have been effective in reducing hepatitis C infection in the general community in the Kingdom of Saudi Arabia but the infection among high risk groups remain a major problem that needs to be actively addressed.

Entities:  

Mesh:

Year:  2003        PMID: 12897907

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  18 in total

1.  Accuracy of rapid oral HCV diagnostic test among a Saudi sample.

Authors:  Suzan Ibrahim; Safia Ali Al Attas; Ghada Anwar Mansour; Soliman Ouda; Hind Fallatah
Journal:  Clin Oral Investig       Date:  2014-05-21       Impact factor: 3.573

2.  Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.

Authors:  Cesar Yaghi; Ala-I Sharara; Paul Rassam; Rami Moucari; Khalil Honein; Joseph BouJaoude; Rita Slim; Roger Noun; Heitham Abdul-Baki; Mohamad Khalifeh; Sami Ramia; Raymond Sayegh
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Osteopontin as a marker for response to pegylated interferon Alpha-2b treatment in Chronic HCV Saudi patients.

Authors:  Yousri Mostafa Hussein; Ayman Alhazmi; Saad Alzahrani; Ahmad El-Askary; Abdulrahman Alghamdy; Eman Bayomy; Assmaa Selim; Mohammed Alghamdy
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

Review 5.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

6.  Prevalence of hepatitis B and C in donated blood from the jazan region of saudi arabia.

Authors:  Saleh Mohammed Abdullah
Journal:  Malays J Med Sci       Date:  2013-03

7.  Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa.

Authors:  Richard Njouom; Mélanie Caron; Guillaume Besson; Guy-Roger Ndong-Atome; Maria Makuwa; Régis Pouillot; Dieudonné Nkoghé; Eric Leroy; Mirdad Kazanji
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

8.  Seroprevalence and Risk Factors for Hepatitis C Virus Infection among General Population in Central Region of Yemen.

Authors:  Rajesh N Gacche; Sadiq K Al-Mohani
Journal:  Hepat Res Treat       Date:  2012-12-18

Review 9.  Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Authors:  Ayman A Abdo; Faisal M Sanai; Faleh Z Al-Faleh
Journal:  Saudi J Gastroenterol       Date:  2012 Nov-Dec       Impact factor: 2.485

10.  Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.

Authors:  Hamad I Al Ashgar; Mohammed Q Khan; Mohammed Al-Ahdal; Sahar Al Thawadi; Ahmad Salem Helmy; Ahmed Al Qahtani; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.